Myelin Basic Protein in CSF and Blood
- 1 September 1982
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 39 (9) , 557-560
- https://doi.org/10.1001/archneur.1982.00510210027006
Abstract
• Serum and CSF levels of myelin basic protein (MBP) were measured in 50 patients with encephalitis of various origins and severity. In nearly 50%, the CSF samples were found to display immunoreactivity to MBP. Positivity was found to be correlated with the severity of the clinical signs. More precisely, it corresponded to cases with suspected extensive brain destruction. No relationship could be observed with the cause of disease. Positive tests of sera were infrequent, even from patients whose CSF was rich in MBP. Longitudinal studies performed on 20 patients who were serially investigated during periods ranging from three weeks to 18 months demonstrated that after an attack, MBP liberation into the CSF persists for one to three weeks. The MBP assay should serve as an index for destruction of nervous tissue.This publication has 8 references indexed in Scilit:
- Radioimmunoassay of myelin basic protein in cerebrospinal fluid and its clinical application to patients with neurological diseasesLife Sciences, 1980
- Radioimmunoassay of the myelin basic protein in biological fluids, conditions improving sensitivity and specificityBiochimie, 1980
- The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous systemJournal of the Neurological Sciences, 1980
- Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disordersAnnals of Neurology, 1980
- Radioimmunoassay of serum myelin basic protein and its application to patients with cerebrovascular accidentClinica Chimica Acta; International Journal of Clinical Chemistry, 1979
- a-albumin (glial fibrillary acidic protein) in normal and pathological human brain and cerebrospinal fluidZeitschrift für Neurologie, 1978
- Radioimmunoassay of human myelin basic protein in tissue extract, cerebrospinal fluid and serum and its clinical application to patients with head injuryClinica Chimica Acta; International Journal of Clinical Chemistry, 1978